Capital Analysts, LLC

SEC CIK: 0001624758
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

DMAC holding history

DiaMedica Therapeutics Inc. in every 13F filed by Capital Analysts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DMAC overview All 13F holders of DMAC Full Q2 2026 holdings

Shares (Q2 2026): 1,050
Value: $7.00K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of DMAC by Capital Analysts, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1,050	$7.00K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	1,050	$7.00K	<0.1%	00.0%	Unchanged	Holders
Q4 2025	1,050	$8.00K	<0.1%	+1,050	New	Holders